SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.85+0.2%Dec 12 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Solid who wrote (4481)7/20/1998 8:18:00 PM
From: BigKNY3   of 9523
 
News From AOL Market Day.

Have PFun!

BigKNY3

WARNER-LAMBERT (WLA) 79 9/16. Drug companies are as hot as tech companies, and ones that beat earnings estimates look like they will keep on going. Before the open on Monday, WLA reported second quarter earnings per share of $0.40, 3 cents ahead of expectations and up from year ago $0.28 as revenue rose 30%. Pretty darn good numbers. The stock is indicated to open 2 to 3 points higher. Drug stocks are typically very reliable in delivering "in-line" earnings numbers. Lately, however, they have been even more reliable in delivering earnings above expectations.

Last week, Pfizer (PFE) also reported blow-out numbers, reporting earnings at $0.47, 3 cents ahead of expectations on July 9, and the stock took off. Drug companies are doing extremely well, and have become trading vehicles not only for the large mutual funds that have always loved them, but for the day trader as well now. Looking ahead to reports from other drug companies, Bristol-Myers (BMY) and Merck (MRK) are both due to report after the close Tuesday.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext